Companion Diagnostics Market
Activities by Major Players to Foster Companion Diagnostics Market Penetration: Key Highlights by FMI
Companion Diagnostics Market by Application, Technology & Region - Forecast 2022 - 2032
Companion Diagnostics Market Outlook (2022-2032)
[333 Pages Report] The global companion diagnostics market is predicted to garner a revenue of about US$ 5152.064939 million by 2032, up from US$ 2452.653722 million in 2022 with a CAGR of 7.1% during the forecast period.
Companion diagnostics is utilized to ascertain who would benefit from treatment and the demand for the same is on the surge as it comes in handy to identify if someone cannot be cured, but also conversely can be harmed by use of specific drug used for their ailment. Moreover, the companion diagnostics market growth is propelled by technological advancements which have brought a lot of changes in the method of disease treatment on the whole.
Companion diagnostics is characterized by growing requirement for enhanced personalized patient treatment that gives healthcare providers and their patients an assurance about the treatment result in a positive way, contrary to traditional treatment procedure, positively impacting the companion diagnostics market outlook.
|
Report Attribute |
Details |
|
Companion Diagnostics Market Value (2022) |
US$ 2452.653722 Million |
|
Companion Diagnostics Market Anticipated Forecast Value (2032) |
US$ 5152.064939 Million |
|
Companion Diagnostics Market Projected Growth Rate (2022-2032) |
7.1% |
The rise in tailored medicine usage in tandem with rising demand for targeted therapies contribute to the creation of customized CDx and the expansion of the worldwide companion diagnostics market size.
Additionally, the advantages of CDx tests, such as their high sensitivity, affordability, and ability to produce accurate results quickly, are driving the expansion of the companion diagnostics market. It is now well accepted that medications can interact differently with different people as a result of advancements in genetic sequencing and genomics.
And the technique of giving "the correct drug, at the right time, at the right dose, for the right person" can be advanced with a greater understanding of a person's genetic traits or biomarkers.
In order to give focused therapeutics to the appropriate candidate, pharmaceutical and biopharmaceutical companies are continuously working to adopt patient-selection diagnostic frameworks in the early stages of drug development. And the same is anticipated to push forward the adoption of companion diagnostics to a considerable extent over the forecast period.
Let us know your requirement to get
100% FREE customization
What are the Key Companion Diagnostics Market Dynamics?
With rapid technological advancement and increase in the incidence of chronic disease, the demand for companion diagnostics is likely to spike, where the major impact of companion diagnostic is likely to be on oncology therapy area. Presently, companion diagnostics global market is driven by the technological advancement in healthcare industry as well as increase in various treatment procedures.
Number of companion diagnostics can be given approval for a single drug as scientific knowledge advances with practical application of treatment.
On the flip side, cost related to the latest technology acts as a key barrier for the global companion diagnostics market growth.
Why is North America Anticipated to Hold a Monopoly over the Companion Diagnostics Market?
North America is the leading market for companion diagnostics with a share of 25.4% in 2022 on account of rapid technical inventions as well as the increasing prevalence of chronic diseases like cancer.
Additionally, companion diagnostics market trends and forecast are swayed expansion of research activities in this field employing companion diagnostic kits and the growing number of healthcare organisations working on genetic databases created to comprehend the human genome.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat is the Growth Outlook for the Companion Diagnostics Market in Europe?
The second-highest market is anticipated to be in Europe with a market share of companion diagnostics market share of 21.6% in 2022.
A substantial number of businesses are expected to participate as the regional sector expands, and research and development efforts to enhance personalized drug therapy for cancer patients are expected to increase, in turn impacting the regional market. Additionally, rising per capita income increases the desire for individualized care, further promoting consumer development.
How is the Start-Up Ecosystem in the Companion Diagnostics Market?
Numerous start-ups have been founded by many eminent personalities, leaving their mark in the companion diagnostics market, in turn auguring well for the companion diagnostics market future trends.
Example:
For the past 18 years, Ali Ardakani has played a crucial role in the founding and growth of numerous biotech businesses, pharmaceuticals, and medical devices, for which he has raised over $100 M USD in private and grant funding.
His most recent venture was the co-founding of the virtual biotech start-up Niiki Pharma Inc. in NYC, where he purchased two first-in-class oncology medications from Europe and expedited their development through UK CTA, US IND, and Phase 1 and 2 clinical trials in under 3 years.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
What is the Competition Landscape in the Companion Diagnostics Market?
The companion diagnostics market is fairly competitive, where players in the market primarily engage acquisitions, product releases, and collaborations as their primary business strategies.
A few of such recent developments in the companion diagnostics market are:
- Therascreen PIK3CA RGQ PCR Kit was introduced by QIAGEN N.V. in PIQRAY (alpelisib) therapy in the US to expand its product line in the Companion Diagnostics Market.
- Thermo Fisher Science Inc. and Agios Pharmaceuticals have partnered strategically to create a second companion oncology diagnostic tool.
- AstraZeneca plc, Merck Group, and Myriad Genetics, Inc. (US) joined forces to find unmet medical needs in men with metastatic castration-resistant prostate cancer and to increase the company's patient access in the market.
Key players:
- ARUP Laboratories
- Roche Molecular Systems Inc.
- Dako Inc.
- Qiagen Ltd.
- bioMérieux Inc.
- Ventana Medical Systems Inc.
- Abbott Molecular Inc.
- Myriad Genetics Inc.
- Biogenex Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Leica Biosystems Nussloch GmbH
- Others
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 7.1% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2014-2020 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in USD Million, Volume in Kilotons and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled in the Companion Diagnostics Market Survey
By Application:
- Colorectal Cancer
- Breast Cancer
- Lung Cancer
- Melanoma
- Urology
- Gastric Cancer
By Technology:
- Immunohistochemistry
- Molecular Diagnostics
- In-situ Hybridization
- FISH
- CISH
- Real Time PCR
- Gene Sequencing
By Region:
- North America
- Latin America
- Asia Pacific
- The Middle East and Africa
- Europe
Frequently Asked Questions
The global companion diagnostics market is likely to advance at 7.1% CAGR (2022-2032).
North America is projected to lead the companion diagnostics market with a share of 25.4% in 2022.
The companion diagnostics market is anticipated to account for US$ 5152.064939 million by 2032.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Companion Diagnostics Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Application
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
5.3.1. Colorectal Cancer
5.3.2. Breast Cancer
5.3.3. Lung Cancer
5.3.4. Melanoma
5.3.5. Urology
5.3.6. Gastric Cancer
5.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
5.5. Absolute $ Opportunity Analysis By Application, 2022-2032
6. Global Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Technology
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032
6.3.1. Immunohistochemistry
6.3.2. Molecular Diagnostics
6.3.3. In-situ Hybridization
6.3.4. FISH
6.3.5. CISH
6.3.6. Real Time PCR
6.3.7. Gene Sequencing
6.4. Y-o-Y Growth Trend Analysis By Technology, 2017-2021
6.5. Absolute $ Opportunity Analysis By Technology, 2022-2032
7. Global Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. South Asia
7.3.5. East Asia
7.3.6. Oceania
7.3.7. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Application
8.2.3. By Technology
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Application
8.3.3. By Technology
8.4. Key Takeaways
9. Latin America Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Application
9.2.3. By Technology
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Application
9.3.3. By Technology
9.4. Key Takeaways
10. Europe Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Application
10.2.3. By Technology
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Application
10.3.3. By Technology
10.4. Key Takeaways
11. South Asia Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Malaysia
11.2.1.3. Singapore
11.2.1.4. Thailand
11.2.1.5. Rest of South Asia
11.2.2. By Application
11.2.3. By Technology
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Application
11.3.3. By Technology
11.4. Key Takeaways
12. East Asia Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Application
12.2.3. By Technology
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Application
12.3.3. By Technology
12.4. Key Takeaways
13. Oceania Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Application
13.2.3. By Technology
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Application
13.3.3. By Technology
13.4. Key Takeaways
14. MEA Companion Diagnostics Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Application
14.2.3. By Technology
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Application
14.3.3. By Technology
14.4. Key Takeaways
15. Key Countries Companion Diagnostics Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Application
15.1.2.2. By Technology
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Application
15.2.2.2. By Technology
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Application
15.3.2.2. By Technology
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Application
15.4.2.2. By Technology
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Application
15.5.2.2. By Technology
15.6. U.K.
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Application
15.6.2.2. By Technology
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Application
15.7.2.2. By Technology
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Application
15.8.2.2. By Technology
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Application
15.9.2.2. By Technology
15.10. India
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Application
15.10.2.2. By Technology
15.11. Malaysia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Application
15.11.2.2. By Technology
15.12. Singapore
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Application
15.12.2.2. By Technology
15.13. Thailand
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Application
15.13.2.2. By Technology
15.14. China
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Application
15.14.2.2. By Technology
15.15. Japan
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Application
15.15.2.2. By Technology
15.16. South Korea
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Application
15.16.2.2. By Technology
15.17. Australia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Application
15.17.2.2. By Technology
15.18. New Zealand
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Application
15.18.2.2. By Technology
15.19. GCC Countries
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Application
15.19.2.2. By Technology
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Application
15.20.2.2. By Technology
15.21. Israel
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2021
15.21.2.1. By Application
15.21.2.2. By Technology
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Application
16.3.3. By Technology
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. ARUP Laboratories
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Dako Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Qiagen Ltd.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. bioMérieux Inc.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Ventana Medical Systems Inc.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Abbott Molecular Inc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Myriad Genetics Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Biogenex Laboratories, Inc.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Thermo Fisher Scientific Inc.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Leica Biosystems Nussloch GmbH
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Companion Diagnostics Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 3: Global Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 4: North America Companion Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 5: North America Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 6: North America Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 7: Latin America Companion Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 8: Latin America Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 9: Latin America Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 10: Europe Companion Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 11: Europe Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 12: Europe Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 13: South Asia Companion Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: South Asia Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 15: South Asia Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 16: East Asia Companion Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 17: East Asia Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 18: East Asia Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 19: Oceania Companion Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 20: Oceania Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 21: Oceania Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 22: MEA Companion Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 23: MEA Companion Diagnostics Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 24: MEA Companion Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032
Figure 2: Global Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 3: Global Companion Diagnostics Market Value (US$ Mn) by Region, 2022-2032
Figure 4: Global Companion Diagnostics Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 5: Global Companion Diagnostics Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 6: Global Companion Diagnostics Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 7: Global Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 8: Global Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 9: Global Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 10: Global Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 11: Global Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 12: Global Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 13: Global Companion Diagnostics Market Attractiveness by Application, 2022-2032
Figure 14: Global Companion Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 15: Global Companion Diagnostics Market Attractiveness by Region, 2022-2032
Figure 16: North America Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032
Figure 17: North America Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 18: North America Companion Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 19: North America Companion Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 20: North America Companion Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 21: North America Companion Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 22: North America Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 23: North America Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 24: North America Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 25: North America Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 26: North America Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 27: North America Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 28: North America Companion Diagnostics Market Attractiveness by Application, 2022-2032
Figure 29: North America Companion Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 30: North America Companion Diagnostics Market Attractiveness by Country, 2022-2032
Figure 31: Latin America Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032
Figure 32: Latin America Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 33: Latin America Companion Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 34: Latin America Companion Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 35: Latin America Companion Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 36: Latin America Companion Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 37: Latin America Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 38: Latin America Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 39: Latin America Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 40: Latin America Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 41: Latin America Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 42: Latin America Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 43: Latin America Companion Diagnostics Market Attractiveness by Application, 2022-2032
Figure 44: Latin America Companion Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 45: Latin America Companion Diagnostics Market Attractiveness by Country, 2022-2032
Figure 46: Europe Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032
Figure 47: Europe Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 48: Europe Companion Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 49: Europe Companion Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 50: Europe Companion Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 51: Europe Companion Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 52: Europe Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 53: Europe Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 54: Europe Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 55: Europe Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 56: Europe Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 57: Europe Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 58: Europe Companion Diagnostics Market Attractiveness by Application, 2022-2032
Figure 59: Europe Companion Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 60: Europe Companion Diagnostics Market Attractiveness by Country, 2022-2032
Figure 61: South Asia Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032
Figure 62: South Asia Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 63: South Asia Companion Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 64: South Asia Companion Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 65: South Asia Companion Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 66: South Asia Companion Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 67: South Asia Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 68: South Asia Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 69: South Asia Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 70: South Asia Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 71: South Asia Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 72: South Asia Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 73: South Asia Companion Diagnostics Market Attractiveness by Application, 2022-2032
Figure 74: South Asia Companion Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 75: South Asia Companion Diagnostics Market Attractiveness by Country, 2022-2032
Figure 76: East Asia Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032
Figure 77: East Asia Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 78: East Asia Companion Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 79: East Asia Companion Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 80: East Asia Companion Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 81: East Asia Companion Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 82: East Asia Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 83: East Asia Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 84: East Asia Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 85: East Asia Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 86: East Asia Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 87: East Asia Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 88: East Asia Companion Diagnostics Market Attractiveness by Application, 2022-2032
Figure 89: East Asia Companion Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 90: East Asia Companion Diagnostics Market Attractiveness by Country, 2022-2032
Figure 91: Oceania Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032
Figure 92: Oceania Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 93: Oceania Companion Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 94: Oceania Companion Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 95: Oceania Companion Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 96: Oceania Companion Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 97: Oceania Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 98: Oceania Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 99: Oceania Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 100: Oceania Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 101: Oceania Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 102: Oceania Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 103: Oceania Companion Diagnostics Market Attractiveness by Application, 2022-2032
Figure 104: Oceania Companion Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 105: Oceania Companion Diagnostics Market Attractiveness by Country, 2022-2032
Figure 106: MEA Companion Diagnostics Market Value (US$ Mn) by Application, 2022-2032
Figure 107: MEA Companion Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 108: MEA Companion Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 109: MEA Companion Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 110: MEA Companion Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 111: MEA Companion Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 112: MEA Companion Diagnostics Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 113: MEA Companion Diagnostics Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 114: MEA Companion Diagnostics Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 115: MEA Companion Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 116: MEA Companion Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 117: MEA Companion Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 118: MEA Companion Diagnostics Market Attractiveness by Application, 2022-2032
Figure 119: MEA Companion Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 120: MEA Companion Diagnostics Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
